3 Biotech Stocks To Avoid
After a history of failures, these three biotech stocks are running out of ideas and cash to keep their operations going.
A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.
After a history of failures, these three biotech stocks are running out of ideas and cash to keep their operations going.
A lot of things happened this past week. Let's check it out.
It will be an interesting week if you know where to look.
A look back at the biggest stories this week in biotech and what they mean for investors.
The Fool looks at 3 horrendous health-care stocks from the past week.
Is this meaningful or just another movement?
What caused shares of this drugmaker to spiral today?
HEAT trial failed. Shares down over 80%. Is there any hope?
A look back at the biggest stories this week in biotech and what they mean for investors.
This agreement adds more suspense as investors await Phase 3 clinical trial results from Celsion.